Where algal DHA is permitted, and what the file must show
Algal DHA is sold as a food-supplement ingredient in the EU, the US and the UK, but permission is route-specific. In the EU the oil is a novel food with a Union-list entry; in the US a dietary ingredient with a GRAS or notification history; the UK a retained framework and its own register. Each file has to show the route, the carrier, the allergen position and the claim boundary for that market.
Permission follows the oil's route into each market, and the file has to show that route, the carrier and the allergen position before the label is written.
Four checks, not one
An omega-3 ingredient is checked at four levels: the route that makes it lawful, the food category and use level, the contaminants, and the label and any claim on it. They fail on their own. A lot can sit inside every metal limit and still be on the wrong route; a route can be right while the label omits the source. “EU compliant” answers at most one of the four.
The European Union
Supplement rules begin with Directive 2002/46/EC, harmonising the vitamin and mineral forms and leaving other substances to national law. Above that sits Regulation (EU) 2015/2283 on novel foods: anything not eaten significantly in the EU before 15 May 1997 requires an authorisation; authorised items are listed in the Union list in Implementing Regulation (EU) 2017/2470. The list carries an entry for DHA-rich oil from Schizochytrium sp. and a separate one for oil from Ulkenia sp.; both carry conditions, including use in supplements and a maximum intake. Confirm the current entry, maximum and designation before the label is set.
The entry authorises the oil, not the powder as a new material: a powder is that oil plus carriers, so entry, use level and carrier status have to line up. Modified starch may fall under the food-additive rules, where its permitted use and E-number need checking; either way it is declared. Labelling follows Regulation (EU) 1169/2011, and a supplement must state the amount of the substance with a nutritional effect in the product, so the DHA figure belongs on the label, not just the COA.
The United States
In the US the powder is a dietary supplement ingredient under DSHEA. Nothing is approved before it is marketed — there is no licence — so the framework is safety, GMP and labelling. The facility follows 21 CFR 111, the label 21 CFR 101, and the ingredient needs a lawful basis — a GRAS position or a new dietary ingredient notification, depending on its history.
DHA-rich algal oil has a GRAS history, with notices filed for the oil; the dietary-ingredient route is usual for a supplement. GRAS status belongs to a substance, source and use, so the supplier should name the notice or notification it relies on. Algae is not a major allergen, but the carrier and any shared line still need checking: fish is, and a fish-free claim depends on the line, not only on the oil.
The United Kingdom
Great Britain applies retained food law: the novel-food Regulation as retained, the GB register kept by the FSA, the food-supplement regulations and the retained labelling and allergen rules. The EU Union list does not apply in GB, so an EU entry is evidence about the oil, not the GB authorisation; the register is what to check. Northern Ireland follows the EU regime, so a product sold across the UK can face two routes.
The allergen list is retained in substance, so the fish entry and the starch-source question are the same as in the EU, and labelling follows the retained 1169/2011 rules, including the amount of the substance. GB needs its own route reference, and a label built only on EU paperwork is incomplete.
Contaminants and the specification
| Parameter | Specification limit | EU ceiling, supplements | Note |
|---|---|---|---|
| Lead | ≤3 mg/kg | 3.0 mg/kg | Regulation (EU) 2023/915 |
| Cadmium | ≤1 mg/kg | 1.0 mg/kg | Higher only for specified seaweed products |
| Mercury | ≤0.1 mg/kg | 0.10 mg/kg | Regulation (EU) 2023/915 |
| Arsenic | ≤2 mg/kg | No harmonised maximum | National or buyer limits apply |
| Moisture | ≤5.0% | Not a regulatory maximum | Quality parameter for the wall |
| PV and p-AV | ≤5.0 meq/kg and ≤20.0 | Not regulatory maxima | A lipid-quality parameter, not a contaminant |
| Microbiology | APC ≤1,000 cfu/g; yeast and mould ≤100 cfu/g; E. coli and Salmonella absent | Agreed in the specification | Agree the criteria with the buyer |
The ceilings apply to the supplement as sold, so the calculation runs on the finished formula. Peroxide and p-anisidine values are lipid-quality parameters, not contaminants; they belong in the specification and the stability file.
Where the claim stops
In the EU and the UK, Regulation 1924/2006 and its GB mirror set the claim rules. Claims must be authorised: the Annex has a nutrition claim for omega-3 fatty acids with a minimum per 100 g and per 100 kcal, and the DHA and EPA health claims carry a fixed wording and a minimum daily intake — 250 mg of DHA for the DHA claims at this review. A 10% powder delivers 100 mg DHA per gram, so the distance between that intake and the serving weight is arithmetic.
In the US a structure/function statement is allowed for a supplement with the required disclaimer; a disease claim is not, unless it is an authorised qualified health claim. The supplier provides the specification and the numbers; the brand owns the wording. No disease-related claim belongs on a DHA specification, a COA or a label.
What the buyer's file should contain
| Document | What it establishes | Common gap |
|---|---|---|
| Specification | Source, grade, methods and limits | No source or carrier line |
| Batch COA | The lot passed its release tests | Results that repeat the range |
| Source and allergen statement | Algal oil, carrier, fish-free position | “Fish-free” claimed without a line check |
| Novel-food reference (EU/GB) | The entry the oil relies on | A generic algal-oil statement with no entry |
| GRAS or NDI reference (US) | The basis for the US safety position | GRAS cited for a different oil or use |
| SDS and stability report | Handling, storage and shelf life | A shelf life with no study |
| Contaminant and micro data | The lot is inside the agreed limits | Panels without methods or LOQs |
Before the file is signed off
- Name the oil source and grade, and match both to the route for that market.
- Confirm the DHA content and GC method on the specification.
- Check the carrier: identity, source, and its status in the market.
- Compare lead, cadmium, mercury, arsenic and the micro panel with the applicable limits.
- Check the label: ingredient name, DHA amount, allergen statement and storage condition.
- Keep the wording inside the authorised list and the applicable register.
- Keep COA, specification, SDS, stability report and route reference in one file.
- Re-check the route when the source, carrier, grade or market changes.
The tests behind the file are on the COA page, the source comparison on the algal versus fish oil page and the allergen list in the Annex II glossary entry. The catalog specification is on the algal DHA powder hub.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation